AU5851494A - Serum pyridinium crosslinks assay - Google Patents

Serum pyridinium crosslinks assay

Info

Publication number
AU5851494A
AU5851494A AU58514/94A AU5851494A AU5851494A AU 5851494 A AU5851494 A AU 5851494A AU 58514/94 A AU58514/94 A AU 58514/94A AU 5851494 A AU5851494 A AU 5851494A AU 5851494 A AU5851494 A AU 5851494A
Authority
AU
Australia
Prior art keywords
serum
assay
pyridinium crosslinks
crosslinks
pyridinium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58514/94A
Other languages
English (en)
Inventor
Baltazar Gomez Jr.
Viola T Kung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metra Biosystems Inc
Original Assignee
Metra Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metra Biosystems Inc filed Critical Metra Biosystems Inc
Publication of AU5851494A publication Critical patent/AU5851494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C19/00—Dental auxiliary appliances
    • A61C19/06—Implements for therapeutic treatment
    • A61C19/063—Medicament applicators for teeth or gums, e.g. treatment with fluorides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU58514/94A 1992-12-17 1993-12-17 Serum pyridinium crosslinks assay Abandoned AU5851494A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US99293692A 1992-12-17 1992-12-17
US99288892A 1992-12-17 1992-12-17
US992936 1992-12-17
US992888 1992-12-17
US3760293A 1993-03-26 1993-03-26
US037602 1993-03-26
US14028493A 1993-10-20 1993-10-20
US140284 1993-10-20
PCT/US1993/012321 WO1994014072A1 (fr) 1992-12-17 1993-12-17 Determination de reticulations de pyrimidium serique

Publications (1)

Publication Number Publication Date
AU5851494A true AU5851494A (en) 1994-07-04

Family

ID=27488456

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58514/94A Abandoned AU5851494A (en) 1992-12-17 1993-12-17 Serum pyridinium crosslinks assay

Country Status (4)

Country Link
JP (1) JP3448295B2 (fr)
AU (1) AU5851494A (fr)
CA (1) CA2151234A1 (fr)
WO (1) WO1994014072A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756361A (en) * 1992-12-17 1998-05-26 Metra Biosystems, Inc. Screening method for periodontal disease
US5661039A (en) * 1995-03-01 1997-08-26 Metra Biosystems, Inc. Perspiration assay for bone resorption
CA2297555A1 (fr) * 1997-07-31 1999-02-11 Metra Biosystems, Inc. Procede de dosage de peptides du collagene
AU2496700A (en) * 1999-01-07 2000-07-24 Quidel Corporation Pyridinium crosslinks assay

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300434A (en) * 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide

Also Published As

Publication number Publication date
WO1994014072A1 (fr) 1994-06-23
JP3448295B2 (ja) 2003-09-22
CA2151234A1 (fr) 1994-06-23
JPH08507140A (ja) 1996-07-30

Similar Documents

Publication Publication Date Title
AU2464892A (en) Assay method
AU4427493A (en) Solid phase assay
AU1321895A (en) Binding assay
AU7190094A (en) Electrofilter
AU7801694A (en) Laminated assay device
AU666605B2 (en) Reagent for endotoxin assay and method for endotoxin assay using the same
AU1322195A (en) Method of assay
AU7440394A (en) Reagent for endotoxin-specific assay
AU4102896A (en) Particle agglutination assay system
AU7041996A (en) Antibody specific for beta1->6N- acetylglucosamininyltransferase
AU7903694A (en) Assays
AU4733993A (en) Reagent for endotoxin-specific assay
AU1141597A (en) Electronically-solid-phase assay biomolecules
AU5545694A (en) Detection of selected antigen-antibody reactions
AU5166493A (en) New reagents for peptide couplings
AUPM425294A0 (en) In-vitro angiogenesis assay
AU3686793A (en) Thermo-actuator
AU1716292A (en) Assay of specific antibody
AU3900893A (en) Quantitative viral assay
AU1449092A (en) Bridge immunoassay
AU5905094A (en) Nucleic acid assay procedure
AU1441795A (en) Automated lead assay
AU5851494A (en) Serum pyridinium crosslinks assay
AU7797994A (en) An assay device
AU5548986A (en) Microtiter-surface-flocculation assay for antigen or antibodyscreening